Premier Breakthroughs 24 is an event centered around advancing the full spectrum of healthcare objectives. We’re proud to support this focus with education and resources about oncology solutions that provide the right tests at the right time. If you’re attending, we invite you to come see us at booth #1600.
NeoGenomics Laboratories’ Post
More Relevant Posts
-
Our goal is clear: to refine the collaboration of oncology professionals with cutting-edge technology. By providing the right tools, we're enabling smarter, faster decisions for those who need it most. #OncologyInnovation #HealthcareGoals #SmartTechnology #AdvancedCare #ProfessionalCollaboration
-
-
MMIT experts will be at #ASCO24 to discuss why the right tools and real-world data can help uncover insights on the #oncology patient journey. Book a meeting with us today. https://ow.ly/zo1I50Ryx1W
-
🌟 Happy #MerlinMonday, Followers! 🌟 How's everyone doing today? 😊 Let's kick off the week with some positivity! Today, our spotlight shines on one of our specialized services: Oncology-Specific Support! 🩺💪 In the dynamic world of oncology clinical trials, specialized support is essential for navigating complex protocols, stringent regulations, and unique patient needs. At Merlin SCC, we offer tailored solutions to meet the unique challenges of oncology research. From protocol design to patient recruitment and safety monitoring, our team provides comprehensive support throughout the trial lifecycle. Trust Merlin SCC to be your partner in advancing oncology research and improving patient outcomes. Choose expertise, choose reliability, choose Merlin SCC for your Oncology-Specific Support needs! #MerlinMonday #OncologySupport #ClinicalTrials #ChooseMerlinSCC #HealthcareInnovation #SupplyChainManagement 🌐
-
As mentioned in a recent Diariofarma article, Spain is addressing critical drug approval delays to streamline processes and enhance patient access to medications. Ongoing debates about CAR-T therapies, a cutting-edge cancer treatment, highlight the complexity of these efforts. This initiative marks a significant step towards a more efficient healthcare system, promising faster approvals and better patient outcomes. Lyfegen is actively involved in Spanish healthcare, supporting advancements through innovative value-based agreements. Learn more here: https://lnkd.in/dnnXjtWS Want to discover what Lyfegen can do for you? Get in touch with David Duro, our VP Sales & Business Development. #ValueBasedHealthcare #HealthcareSpain #MarketAccess #HealthcareInnovation
-
Early/Late Phase and Regulatory Strategy, RWE & RWD, Market Access, Logistics at Parexel Biotech
In this edition of the New Medicines, Novel Insights newsletter, Stacy Hurt, M.H.A., M.B.A., Chief Patient Officer, Kristina Reeder, Director, Patient Insights, and Nichola Gokool, Vice President, Customer Strategy and Innovation, Medical Communications, review the critical importance of the patient's voice throughout clinical development. Learn why this is so important in oncology trials, steps for understanding and amplifying patient perspectives, and how Parexel experts are tailoring research processes to the people the therapies are intended to serve. Read the full article and subscribe to receive the latest #NovelInsights each week! https://lnkd.in/ei_XUj8c #Oncology #PatientsFirst #PatientPerspectives #PatientVoice
-
-
Clinical lives save lives! Dive into the world of clinical trials and discover the key players shaping healthcare innovation. From Principal Investigators to Sponsors, learn about the teamwork driving breakthroughs! At LACN, our doctors are very experienced and involved in oncology clinical trials. Read our latest blog, uncovering all of the clinical trial basics: https://loom.ly/esAYeAk #ClinicalTrials #HealthcareInnovation #MedicalResearch
-
In this edition of the New Medicines, Novel Insights newsletter, Stacy Hurt, M.H.A., M.B.A., Chief Patient Officer, Kristina Reeder, Director, Patient Insights, and Nichola Gokool, Vice President, Customer Strategy and Innovation, Medical Communications, review the critical importance of the patient's voice throughout clinical development. Learn why this is so important in oncology trials, steps for understanding and amplifying patient perspectives, and how Parexel experts are tailoring research processes to the people the therapies are intended to serve. Read the full article and subscribe to receive the latest #NovelInsights each week! https://lnkd.in/gDdAjn86 #Oncology #PatientsFirst #PatientPerspectives #PatientVoice
-
-
PatientView has published the results of its latest 📙 “Corporate Reputation of Pharma from a Patient Perspective” survey. We are proud to report that our ranking has risen 3 places since last year. In this report, we are ranked No. 11 💪, a ranking established by patient groups who work with us. We have also maintained our TOP 3 position in the rankings by patient groups who work with us in oncology. At Servier, we are particularly attentive to working with patients and the organizations that represent them during each stage of the medicine life cycle. According to Nicolas Garnier, Chief Patient Officer: 🗣“As we speak, we have over 250 projects with patient organizations across the world”. Learn more 👉 https://swll.to/8G4A6z #PatientView23 #patient #commitment #reputation #WeAreServier #MovedByYou
-
In this edition of the New Medicines, Novel Insights newsletter, Stacy Hurt, M.H.A., M.B.A., Chief Patient Officer, Kristina Reeder, Director, Patient Insights, and Nichola Gokool, Vice President, Customer Strategy and Innovation, Medical Communications, review the critical importance of the patient's voice throughout clinical development. Learn why this is so important in oncology trials, steps for understanding and amplifying patient perspectives, and how Parexel experts are tailoring research processes to the people the therapies are intended to serve. Read the full article and subscribe to receive the latest #NovelInsights each week! https://lnkd.in/eXHkFdR7 #Oncology #PatientsFirst #PatientPerspectives #PatientVoice
-
-
DaSH Global senior management will be attending the ESMO meeting in Barcelona in September. Meet DaSH Global to discuss our approach to MedTech Real World Research Studies and how we are harnessing Patient Reported Outcomes (PROMs) linked to Clinical Outcomes in Lung Cancer and Mesothelioma. Contact us on info@dash-global.com to book a time to speak with one of us and discover how we can enhance your clinical research program. DaSH Global: Improving Outcomes. Transforming Lives. Bridging The Gap Between People, Health & Pharma. #DrugDiscovery #ClinicalResearch #Pharma #NHS #MarketAccess #CancerResearch #RWE #HEOR #HealthData #OutcomesResearch #Mesothelioma #LungCancer #ESMO2024 #MedicalAffairs #Digital Health #BloodCancers #PatientAdvocacy Lee Wemyss Andrew Turner Vivienne Law Mesothelioma UK HASAG Asbestos Disease Support
-
Medical Billing & RCM Expert | 📈Upto $5M Monthly Claimed in the last 6 months | 🏆 Expert in Denial & AR Management | 🚀 Reducing AR & Creating Clean Claims | Streamlining Your Billing, Simplifying Your Life.🤟
2moInteresting event